Sign Up to like & get
recommendations!
1
Published in 2021 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.27911
Abstract: DNA modification plays a pivotal role in regulating gene expression in cell development. As prevalent markers on DNA, 5‐methylcytosine (5mC), N6‐methyladenine (6mA), and N4‐methylcytosine (4mC) can be recognized by specific methyltransferases, facilitating cellular defense and…
read more here.
Keywords:
5mc methyladenine;
6ma methylcytosine;
methylcytosine 5mc;
methyladenine 6ma ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2022 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.28042
Abstract: Biotechnol Bioeng. 2022;119:1171. wileyonlinelibrary.com/journal/bit © 2022 Wiley Periodicals LLC | 1171 On page 4208, the text “TAPS uses a standard modification‐ calling tool called asTair (H. Li & Durbin, 2009),” should read “TAPS uses a…
read more here.
Keywords:
mapping epigenetic;
erratum advances;
methylcytosine 5mc;
modifications methylcytosine ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Epigenetics"
DOI: 10.1186/s13148-018-0540-x
Abstract: BackgroundPrognostic tools for prostate cancer (PC) are inadequate and new molecular biomarkers may improve risk stratification. The epigenetic mark 5-hydroxymethylcytosine (5hmC) has recently been proposed as a novel candidate prognostic biomarker in several malignancies including…
read more here.
Keywords:
formylcytosine 5fc;
hydroxymethylcytosine 5hmc;
5cac levels;
prostate cancer ... See more keywords